Combination of Ifosfamide,Methotrexate, VP-16, and Bleomycin (IMV-BLEO) as Salvage Therapy for Non-Hodgkin’s Lymphoma
1987
SummaryIn an ongoing study, 29 patients with non-Hodgkin’s lymphoma (NHL), which was resistant to CHOP treatment were treated with IMV-BLEO combination therapy. Twelve patients (41%) achieved complete
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
6
Citations
NaN
KQI